|
|
1401 Harbor Bay Parkway
Alameda, CA 94502-7070 USA
phone:(510) 749-4200
fax:
|
|
| Symbol |
CRA |
| Exchange |
NASDAQ GS |
| Founded |
0 |
| Employees |
|
|
|
| www.celeradiagnostics.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Molecular diagnostics for infectious disease testing and genetic conditions such as cystic fibrosis. |
|
| Management |
| Paul Arata, Vice President, Human Resources and Administration; Samuel Broder, Chief Medical Officer; Christopher Hall, Chief Business Officer of Berkeley HeartLab; Joel Jung, Chief Financial Officer; Scott Milsten, Vice President, General Counsel and Corporate Secretary; Kathy Ordo?ez, Chief Executive Officer; Stacey Sias, Chief Business Officer; G. Russell Warnick, Chief Scientific Officer, Berkeley HeartLab, Inc; Thomas White, Chief Scientific Officer, Celera; Michael Zoccoli, General Manager - Products Business |
| |
|
|
|
|
|
|
|
| Keywords |
| molecular diagnostics, infectious disease, gnetic, cystic fibrosis, genotyping, HIV, HCV, advamed, HIVAIDS, InfectiousDisease |
|
|
|
| Description |
|
Celera Diagnostics discovers, develops and commercializes molecular diagnostics for infectious disease testing and for genetic conditions such as cystic fibrosis. |
|
| Products / Services |
Celera provides the following products: ViroSeq HIV-1 Genotyping System - for use in testing human blood samples and was designed to detect specific mutations in the HIV-1 genome that correlate with drug resistance; Cystic Fibrosis Analyte Specific Reagents, for the detection of mutations in the CFTR gene; HCV Genotyping ASRs, used to identify the genotypes of the different strains of HCV; HCV Quantitative ASRs, for the quantitative determination of HCV.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
